YY1 modulates the radiosensitivity of esophageal squamous cell carcinoma through KIF3B-mediated Hippo signaling pathway

YY1 modulates the radiosensitivity of esophageal squamous cell carcinoma through KIF3B-mediated Hippo signaling pathway

Abstract Radiotherapy is an important strategy in the comprehensive treatment of esophageal squamous cell carcinoma (ESCC). However, effectiveness of radiotherapy is still restricted by radioresistance. Herein, we aimed to understand the mechanisms underlying ESCC radioresistance, for which we looke...

Full description

Bibliographic Details
Main Authors:	Chunyan Zheng, Zhe Li, Chuanxi Zhao, Xiaoyang Yin, Lei Feng, Zhongtang Wang, Chengxin Liu, Baosheng Li
Format:	Article
Language:	English
Published:	Nature Publishing Group 2023-12-01
Series:	Cell Death and Disease
Online Access:	https://doi.org/10.1038/s41419-023-06321-x

Similar Items

SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis
by: Lei Feng, et al.
Published: (2021-08-01)

A Circ-0007022/miR-338-3p/Neuropilin-1 Axis Reduces the Radiosensitivity of Esophageal Squamous Cell Carcinoma by Activating Epithelial-To-Mesenchymal Transition and PI3K/AKT Pathway
by: Junpeng Zhang, et al.
Published: (2022-04-01)

Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway
by: Ma Lijuan, et al.
Published: (2023-09-01)

KIF4A enhanced cell proliferation and migration via Hippo signaling and predicted a poor prognosis in esophageal squamous cell carcinoma
by: Xiaozheng Sun, et al.
Published: (2021-02-01)

Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma
by: Lingbo An, et al.
Published: (2023-08-01)

SHARPIN Inhibits Esophageal Squamous Cell Carcinoma Progression by Modulating Hippo Signaling
by: Aijia Zhang, et al.
Published: (2020-02-01)

Sintilimab as maintenance treatment for local/regional recurrent esophageal squamous carcinoma after concurrent chemoradiotherapy: a single-arm Ib/II phase study
by: Chengxin Liu, et al.
Published: (2023-05-01)

Bone marrow dosimetric analysis of lymphopenia in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy
by: Qian Wang, et al.
Published: (2021-09-01)

The significance of Hippo pathway protein expression in oral squamous cell carcinoma
by: Yusuke Amano, et al.
Published: (2024-02-01)

Baicalein Inhibits the Progression and Promotes Radiosensitivity of Esophageal Squamous Cell Carcinoma by Targeting HIF-1A
by: Guo D, et al.
Published: (2022-07-01)

Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3
by: Zhao Lei, et al.
Published: (2012-12-01)

NS1-binding protein radiosensitizes esophageal squamous cell carcinoma by transcriptionally suppressing c-Myc
by: Yuwen Wang, et al.
Published: (2018-06-01)

A combined nomogram based on radiomics and hematology to predict the pathological complete response of neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma
by: Yu Yang, et al.
Published: (2024-04-01)

Aspirin Exerts Its Antitumor Effect in Esophageal Squamous Cell Carcinoma by Downregulating the Expression of ATAD2 and KIF4A
by: Man Zhang, et al.
Published: (2022-01-01)

Gallic acid from Terminalia chebula inhibited the growth of esophageal carcinoma cells by suppressing the Hippo signal pathway
by: Gui-Li Sun, et al.
Published: (2020-11-01)

Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma
by: Yanping Gao, et al.
Published: (2017-11-01)

The Characteristic of S100A7 Induction by the Hippo-YAP Pathway in Cervical and Glossopharyngeal Squamous Cell Carcinoma.
by: Fei Kong, et al.
Published: (2016-01-01)

SOCS6 promotes radiosensitivity and decreases cancer cell stemness in esophageal squamous cell carcinoma by regulating c-Kit ubiquitylation
by: Xuanzi Sun, et al.
Published: (2021-03-01)

LINC02532 Contributes to Radiosensitivity in Clear Cell Renal Cell Carcinoma through the miR-654-5p/YY1 Axis
by: Xiaoguang Zhou, et al.
Published: (2021-11-01)

NVP-BSK805, an Inhibitor of JAK2 Kinase, Significantly Enhances the Radiosensitivity of Esophageal Squamous Cell Carcinoma in vitro and in vivo
by: Hua Y, et al.
Published: (2020-02-01)

DEPDC1 and KIF4A synergistically inhibit the malignant biological behavior of osteosarcoma cells through Hippo signaling pathway
by: Mingming Yang, et al.
Published: (2023-02-01)

CD155 promotes radioresistance and malignancy of esophageal cancer by regulating Hippo-YAP pathway
by: Huixian Xin, et al.
Published: (2022-06-01)

Integrating Genetic Alterations and the Hippo Pathway in Head and Neck Squamous Cell Carcinoma for Future Precision Medicine
by: Toshinori Ando, et al.
Published: (2022-09-01)

Genome-wide CRISPR screens of oral squamous cell carcinoma reveal fitness genes in the Hippo pathway
by: Annie Wai Yeeng Chai, et al.
Published: (2020-09-01)

MicroRNA-381 Enhances Radiosensitivity in Esophageal Squamous Cell Carcinoma by Targeting X-Linked Inhibitor of Apoptosis Protein [Retraction]
by: Zhou S, et al.
Published: (2023-05-01)

FOXK1 regulates malignant progression and radiosensitivity through direct transcriptional activation of CDC25A and CDK4 in esophageal squamous cell carcinoma
by: Xiaoxu Li, et al.
Published: (2023-05-01)

Silencing KIF18B enhances radiosensitivity: identification of a promising therapeutic target in sarcoma
by: Wensi Liu, et al.
Published: (2020-11-01)

Inactivation of Hippo pathway characterizes a poor-prognosis subtype of esophageal cancer
by: Zihang Mai, et al.
Published: (2022-08-01)

CircPUM1 Knockdown Confers Radiosensitivity in Oral Squamous Cell Carcinoma by Regulating the miR-580/STAT3 Pathway
by: Linghui Jia, et al.
Published: (2022-08-01)

Hippo Pathway Core Genes Based Prognostic Signature and Immune Infiltration Patterns in Lung Squamous Cell Carcinoma
by: Chang Gu, et al.
Published: (2021-04-01)

Pattern of Recurrence in 428 Patients With Thoracic Esophageal Squamous Cell Carcinoma After Radical Surgery and Its Implication in Postoperative Radiotherapeutic Clinical Target Volume
by: Tiantian Cui, et al.
Published: (2021-04-01)

Mutual communication between radiosensitive and radioresistant esophageal cancer cells modulates their radiosensitivity
by: Congying Xie, et al.
Published: (2023-12-01)

Response Prediction to Concurrent Chemoradiotherapy in Esophageal Squamous Cell Carcinoma Using Delta-Radiomics Based on Sequential Whole-Tumor ADC Map
by: Dianzheng An, et al.
Published: (2022-03-01)

Ivermectin induces apoptosis of esophageal squamous cell carcinoma via mitochondrial pathway
by: Nana Xu, et al.
Published: (2021-12-01)

Guidelines for Radiotherapy of Esophageal Carcinoma (2020 Edition)
by: Heyi Gong, et al.
Published: (2021-06-01)

Prognostic Value of Texture Analysis Based on Pretreatment DWI-Weighted MRI for Esophageal Squamous Cell Carcinoma Patients Treated With Concurrent Chemo-Radiotherapy
by: Zhenjiang Li, et al.
Published: (2019-10-01)

Activating the Hippo pathway by nevadensin overcomes Yap-drived resistance to sorafenib in hepatocellular carcinoma
by: Hewen Shi, et al.
Published: (2023-05-01)

Characterization of Esophageal Microbiota in Patients With Esophagitis and Esophageal Squamous Cell Carcinoma
by: Zongdan Jiang, et al.
Published: (2021-11-01)

Trichostatin A promotes esophageal squamous cell carcinoma cell migration and EMT through BRD4/ERK1/2‐dependent pathway
by: Danhui Liu, et al.
Published: (2021-08-01)

Photodynamic Therapy as a Potent Radiosensitizer in Head and Neck Squamous Cell Carcinoma
by: Won Jin Cho, et al.
Published: (2021-03-01)